Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension.

Quinaglia T, de Faria AP, Fontana V, Barbaro NR, Sabbatini AR, Sertório JT, Demacq C, Tanus-Santos JE, Moreno H.

Eur J Clin Pharmacol. 2013 Dec;69(12):2027-36. doi: 10.1007/s00228-013-1571-z. Epub 2013 Aug 21.

PMID:
23963046
2.

Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension.

Santos RC, de Faria AP, Barbaro NR, Modolo R, Ferreira-Melo SE, Matos-Souza JR, Coelho OR, Yugar-Toledo JC, Fontana V, Calhoun D, Moreno H.

Eur J Clin Pharmacol. 2014 Feb;70(2):147-54. doi: 10.1007/s00228-013-1611-8. Epub 2013 Nov 24.

PMID:
24271647
4.

Effects of PDE type 5 inhibitors on left ventricular diastolic dysfunction in resistant hypertension.

Faria AP, Modolo R, Moreno BV, Moreno H.

Arq Bras Cardiol. 2015 Jan;104(1):85-9. doi: 10.5935/abc.20140159. Epub 2014 Oct 28. Review. English, Portuguese.

5.

Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.

Yin J, Kukucka M, Hoffmann J, Sterner-Kock A, Burhenne J, Haefeli WE, Kuppe H, Kuebler WM.

Circ Heart Fail. 2011 Mar;4(2):198-206. doi: 10.1161/CIRCHEARTFAILURE.110.957050. Epub 2011 Jan 7. Erratum in: Circ Heart Fail. 2011 May 1;4(3):e13.

6.

Sildenafil exposure and hemodynamic effect after stage II single-ventricle surgery.

Hill KD, Tunks RD, Barker PC, Benjamin DK Jr, Cohen-Wolkowiez M, Fleming GA, Laughon M, Li JS.

Pediatr Crit Care Med. 2013 Jul;14(6):593-600. doi: 10.1097/PCC.0b013e31828aa5ee.

7.

The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.

Lang M, Kojonazarov B, Tian X, Kalymbetov A, Weissmann N, Grimminger F, Kretschmer A, Stasch JP, Seeger W, Ghofrani HA, Schermuly RT.

PLoS One. 2012;7(8):e43433. doi: 10.1371/journal.pone.0043433. Epub 2012 Aug 17.

8.

Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo.

Bishu K, Hamdani N, Mohammed SF, Kruger M, Ohtani T, Ogut O, Brozovich FV, Burnett JC Jr, Linke WA, Redfield MM.

Circulation. 2011 Dec 20;124(25):2882-91. doi: 10.1161/CIRCULATIONAHA.111.048520. Epub 2011 Dec 5.

9.

Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics.

Matamis D, Pampori S, Papathanasiou A, Papakonstantinou P, Tsagourias M, Galiatsou E, Koulouras V, Nakos G.

Circ Heart Fail. 2012 Jan;5(1):47-53. doi: 10.1161/CIRCHEARTFAILURE.111.963314. Epub 2011 Nov 4.

10.

Effects of sildenafil citrate on human hemodynamics.

Jackson G, Benjamin N, Jackson N, Allen MJ.

Am J Cardiol. 1999 Mar 4;83(5A):13C-20C.

PMID:
10078538
11.

Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat.

Rossoni G, Manfredi B, De Gennaro Colonna V, Berti M, Guazzi M, Berti F.

Br J Pharmacol. 2007 Mar;150(5):567-76. Epub 2007 Jan 22.

12.

Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism.

Dias-Junior CA, Neto-Neves EM, Montenegro MF, Tanus-Santos JE.

Nitric Oxide. 2010 Dec 15;23(4):284-8. doi: 10.1016/j.niox.2010.08.004. Epub 2010 Sep 4.

PMID:
20804854
13.
14.

Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.

Attinà TM, Malatino LS, Maxwell SR, Padfield PL, Webb DJ.

J Hypertens. 2008 Mar;26(3):501-7. doi: 10.1097/HJH.0b013e3282f382ff.

PMID:
18300861
15.

Avanafil, a highly selective phosphodiesterase type 5 inhibitor for erectile dysfunction, shows good safety profiles for retinal function and hemodynamics in anesthetized dogs.

Mochida H, Yano K, Inoue H, Yee S, Noto T, Kikkawa K.

J Urol. 2013 Aug;190(2):799-806. doi: 10.1016/j.juro.2013.01.017. Epub 2013 Jan 12.

PMID:
23321580
16.

Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial.

Andersen MJ, Ersbøll M, Axelsson A, Gustafsson F, Hassager C, Køber L, Borlaug BA, Boesgaard S, Skovgaard LT, Møller JE.

Circulation. 2013 Mar 19;127(11):1200-8. doi: 10.1161/CIRCULATIONAHA.112.000056. Epub 2013 Feb 13.

17.

Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction.

Muniz JJ, Lacchini R, Sertório JT, Jordão AA Jr, Nobre YT, Tucci S Jr, Martins AC, Tanus-Santos JE.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Sep;386(9):805-11. doi: 10.1007/s00210-013-0882-z. Epub 2013 May 19.

PMID:
23685845
18.

Phosphodiesterase type 5 inhibition improves arterial stiffness after exercise but not exercise capacity in hypertensive men.

Attinà TM, Drummond ID, Malatino LS, Maxwell SR, Webb DJ.

Am J Hypertens. 2013 Mar;26(3):342-50. doi: 10.1093/ajh/hps057. Epub 2013 Jan 7.

PMID:
23382484
19.

Sildenafil exposure and hemodynamic effect after Fontan surgery.

Tunks RD, Barker PC, Benjamin DK Jr, Cohen-Wolkowiez M, Fleming GA, Laughon M, Li JS, Hill KD.

Pediatr Crit Care Med. 2014 Jan;15(1):28-34. doi: 10.1097/PCC.0000000000000007.

20.

[Effect of sildenafil on haemodynamic parameters of pulmonary circulation and physical capacity in patients with systolic chronic heart failure with secondary severe pulmonary hypertension].

Josiak K, Inorowicz E, Petruk-Kowalczyk J, Kremis E, Wilczyński J, Zymliński R, Biegus J, Jankowska E, Banasiak W, Ponikowski P.

Kardiol Pol. 2011;69(5):517-9. Polish. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk